Publications & Media

Peer-Reviewed Journal Articles

  • 2026

    • Patient Experiences With Antibody-Drug Conjugates: Bridging Efficacy and Quality of Life in Metastatic Breast Cancer Care – Journal of Patient Experience

    • A Patient-Led Survey of Antibody Drug Conjugate Usage and Dosing for People Living With Metastatic Breast Cancer – Journal of Patient Experience

  • 2024
    • The patient perspective on dose optimization for anticancer treatments: A new era of cancer drug dosing—Challenging the “more is better” dogma – Clinical Trials

  • 2023
    • The Right Dose: Results of a Patient Advocate-Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Related Side Effects and Views About Dosage Assessment to Optimize Quality of Life – JCO Oncology Practice

  • 2022
    • Patient-centered dosing: Oncologists’ perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC) – Breast Cancer Research and Treatment

Media & News Coverage

2025

2024

2021

2020

Talks & Podcasts

  • Coming Soon: Registration is open for a free webinar on Thursday, Oct. 29, 2026, at 12:00 p.m. ET presented by PCDI, Project Life, and METAvivor. Register now

  • October 2026 – Live From Stage 4 Podcast with Victoria Goldberg, featuring Martha Carlson, Kelly Shanahan, AJ Veach, Dr. Mya Roberson, and Dr. Liza Lerner Papautsky – Listen here

  • May 1, 2022 – Health Design Podcast with Sheila McGlown and Julia Maués – Listen here

  • June 2021 – ASCO 2021 Summary by Dr. Lisa Carey – Watch here (starts at minute 19:40)

FDA & Conference Engagements

  • June 2026 – Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting, Melbourne, Australia: PCDI member Martha Carlson presented our poster on the research showing patient-centered dosing for ADCs can improve both treatment outcomes and quality of life. Download PDF

  • December 2025 – San Antonio Breast Cancer Symposium (SABCS): PCDI member Dr. Amy Beumer presented our poster: Dose reductions in metastatic breast cancer patients: Frequency, strategies, and patient experience. Download PDF

  • October 2025 – JADPRO Live Conference, Maryland: PCDI team presented our poster: Patient-Reported Toxicity with Antibody-Drug Conjugate Use in Metastatic Breast Cancer. Download PDF

  • Nov. 2021 – Friends of Cancer Research Annual Meeting: PCDI joins national stakeholders in a pivotal discussion on optimizing dose in oncology drug development – Watch here

  • March 2022 - FDA OCE Conversations on Cancer – “More Isn’t Always Better: Understanding Cancer Treatment Tolerability” – Watch here